Invited Speaker
T. Dianne Langford, PhD
Associate Dean, Research & Professor, Neural Sciences
Professor, Center for Substance Abuse Research,
Temple University, Philadelphia
Invited Speaker
Rohit Bakshi, MD, MA
Jack, Sadie and David Breakstone Professor of Neurology and Radiology, Brigham and Women's Hospital, Harvard Medical School; Director, Laboratory for Neuroimaging Research; Senior Neurologist, Brigham Multiple Sclerosis Center, Boston
A Hybrid Event on Current Brain & Behavioral Health Research and Community Programs in New Mexico.
KEYNOTE PRESENTATION
“Encoding of space and time in cortical structures” by Michael E. Hasselmo, D.Phil, Director, Center for Systems Neuroscience, Boston University
UNM SCHOOL OF MEDICINE & THE MIND RESEARCH NETWORK
Speakers
C. William (Bill) Shuttleworth, PhD
Regents' Professor & Department Chair, UNM School of Medicine, Department of Neurosciences
Andrew R. Mayer, PHD
Vice President of Interdisciplinary Science; Professor of Translational Neuroscience, The Mind Research Network. Adjunct Associate Professor of Neurology and Psychiatry, University of New Mexico Health Science Center
Davin Quinn, MD
Director, UNM Transcranial Magnetic Stimulation Service; Associate Professor , Department of Psychiatry and Behavioral Sciences , UNM School of Medicine; Chief, Division of Behavioral Health Consultation and Integration
Andrew P. Carlson, MD
Associate Professor, UNM School of Medicine, Department of Neurosurgery
UNM DEPARTMENT OF ANESTHESIOLOGY & CRITICAL CARE MEDICINE
Speakers
Karin Westlund High, PhD, Vice Chair of Research & Professor
Sascha R.A. Alles, PhD, Assistant Research Professor
Lightning Talks
Reza Ehsanian, MD, PhD, PGY 4 Resident, Division of Physical Medicine and Rehabilitation, Department of Orthopedics & Rehabilitation
Aleyah E. Goins, BA, Graduate Student, UNM School of Medicine
A virtual event on Current Brain & Behavioral Health Research and Community Programs in New Mexico. Formally known as Neuroscience Day, the signature event for the Brain & Behavioral Health Institute (BBHI), this event is designed to foster multidisciplinary collaboration in brain and behavioral health research in New Mexico and to engage community organizations and learn about their programs in brain and behavioral health.
KEYNOTE PRESENTATION
“From Bench to Bedside – Translating a Neuroprotectant for Stroke from the Lab to Phase 3 Trials (During a Pandemic)” by Michael Tymianski, MD, PhD, FRCSC, Professor of Surgery and Physiology, University of Toronto, Canada
POSTER COMPETITION INFORMATION
Students, postdoctoral fellows, residents & other trainees and community organizations are eligible for the “opt-in” competition part of the poster session. For academic research posters: three monetary awards will be given among three categories (basic science, clinical research & population health). $500 first place, $250 second place, $125 third place. For community organizations, a $250 award will be given to two finalists.
Jessie R. Maxwell, MD
Assistant Professor of Pediatrics and Neurosciences, Division of Neonatology;
Associate Fellowship Director;
Director of Research, Neonatology Division;
University of New Mexico
"Developmental Alterations Following Prenatal Alcohol Exposure: How the Placenta Can Provide Insight."
Drinking alcohol during pregnancy results in exposure of the fetus to alcohol, as there is transfer across the placenta. This can have devastating impacts on the fetus, including significant neurodevelopmental abnormalities. My preclinical research has investigated the impact prenatal alcohol exposure, often in conjunction with another exposure, can have on the developing brain. When combined with a prenatal model of chorioamnionitis, there was a high mortality rate, which was rather unexpected. This has resulted in my further investigation into the alterations in inflammatory responses and immune dysfunction following prenatal alcohol exposure. Today I will be discussing my work in prenatal alcohol exposure, including my recent investigations of human cord blood samples following prenatal alcohol exposure.
MSI STEM Research & Development Consortium (MSRDC)
"MSI STEM Research & Development Consortium: Leveraging Your Research Track Record & Relationships for Direct Awards."
The MSI STEM Research & Development Consortium (MSRDC) is a solutions provider, research development partner and strategic asset to more than 60 minority-serving research institutions, industry and government partners. MSRDC members use a combination of basic, applied, and/or advanced technology development research to pioneer groundbreaking solutions. MSRDC helps the United States maintain a competitive technological advantage, both at home and abroad through a combination of research, collective expertise and a collaborative platform that drives innovation forward.
Panelists: Ahsan Choudary, MPH, CPH, CAPM, Assistant Director of Research Development; Alan Arnold, PhD, Director of Research Development; Alex Thome, PhD, Research Enterprise Development SME
Linda R. Watkins, PhD
University of Colorado Distinguished Professor
“Listening” and “Talking” to Neurons:
Non-neuronal cells amplify pain and drug reward
Pathways from basic science to human and veterinary clinical trials
Re-entering Clinical Research on Substance Use Disorder in the SARS-CoV-2/COVID-19 Era.
Panelists: Snehal Bhatt, MD, Valerie Carrejo, MD, Cameron Crandall, MD, Sarah Doorley, MD, Daniel Williams, PhD.
The Southwest Clinical Trials Network is excited to announce an upcoming opportunity to interface with a virtual panel of frontline clinicians and researchers to discuss tips, tricks, and practice changes in response to SARS-CoV-2/COVID-19 that have occurred in their work with patients with substance use disorders. This event is co-hosted with the UNM Brain & Behavioral Health Institute (BBHI).
Michel T. Torbey, MD, MPH
Professor and Chairman,Departments of Neurology,
University of New Mexico, Albuquerque
Coronavirus: What does Covid-19 do to the brain?
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health threat. Some COVID-19 patients have exhibited widespread neurological manifestations. In this talk, we will review the clinical manifestations of COVID-19 and its impact on the brain both short term and long term. We will also discuss signs and symptoms of brain involvement.
Implementation Science: What is it and why is it important?
Theresa H. Cruz, PhD
Research Associate Professor, Department of Pediatrics,
Deputy Director, UNM Prevention Research Center,
University of New Mexico, Albuquerque
Implementation science is the study of how to translate research evidence into routine practice and policy in the fields of health care and public health in order to improve outcomes at the population level. Historically, substantial time passes between the discovery of a research innovation and the regular use of that innovation – a gap between research and practice. Implementation science is used to bridge this gap by identifying how new treatments, interventions, policies and practices are implemented in the real world, and studying strategies that can be used to increase adoption and wide-spread use.